Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
about
Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulationAn overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma proteinComponents of an interdependent unit within the SSU processome regulate and mediate its activity.Tumor suppressors and cell-cycle proteins in lung cancerMatrine inhibits vascular smooth muscle cell proliferation by modulating the expression of cell cycle regulatory genes.Interaction of fish aryl hydrocarbon receptor paralogs (AHR1 and AHR2) with the retinoblastoma protein.17Alpha-estradiol arrests cell cycle progression at G2/M and induces apoptotic cell death in human acute leukemia Jurkat T cellsPhosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain bindingIntegrated stability and activity control of the Drosophila Rbf1 retinoblastoma protein.The B-domain lysine patch of pRB is required for binding to large T antigen and release of E2F by phosphorylationRB activation defect in tumor cell linesPhosphorylation of the cyclin-dependent kinase inhibitor p21Cip1 on serine 130 is essential for viral cyclin-mediated bypass of a p21Cip1-imposed G1 arrest.Cyclin D does not provide essential Cdk4-independent functions in Drosophila.Selectivity and potency of cyclin-dependent kinase inhibitors.Mitogenic Signaling by the gep Oncogene Involves the Upregulation of S-Phase Kinase-Associated Protein 2.Mice thrive without Cdk4 and Cdk2.Cell cycle activation and spinal cord injury.Generation of a Retinoblastoma (Rb)1-inducible dominant-negative (DN) mouse model.A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations.Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotargetSalivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour.Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.Development of mice expressing a single D-type cyclin.Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicityPhospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck.Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells.Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignanciesImmunohistochemical investigation of F344/N rat islet cell tumors from national toxicology program studiesMinichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasiaEstrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cycliGATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium.Regulation of the retinoblastoma proteins by the human herpesviruses.Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cellsEpstein-Barr virus infection correlates with the expression of COX-2, p16(INK4A) and p53 in classic Hodgkin lymphoma.Investigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjects.Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.Diversity within the pRb pathway: is there a code of conduct?Deciphering the retinoblastoma protein phosphorylation code.Tale of a tegument transactivator: the past, present and future of human CMV pp71
P2860
Q27640571-08B067C2-9E4D-4B13-862E-830EEC3B8160Q27663961-01DFBA3C-9B67-4B0C-AF2E-2F3E4167D659Q27931944-0544BD29-7200-4F0D-BE89-2A425218BF6FQ28392478-24F88B9F-5303-4A26-B71A-AB55A0E348E2Q33577650-C613FECE-8657-4E31-9577-98B90025A32CQ33708404-5A68C9FB-6205-4B68-975D-09F8B6CDAECBQ33786532-684E991C-FB72-4AEC-BC92-16D73DA64846Q33855297-038F2A97-3223-46FA-9FA8-F4B29EB454C2Q34138952-DE84A6F7-C10B-44DD-8604-97F8A57F7BB9Q34302524-435C188E-8D61-4279-A12A-79777A87F55FQ34392704-E0953216-BAD2-45AD-8E0D-DF1DB8517D24Q34519840-3CF7B656-B46A-4EB7-990D-9C33B493B453Q34569850-8D2B9037-BA95-4A4D-A56C-084B75D6D8A8Q34651981-135DE3EF-365C-4228-903F-7E4E95E4B3ECQ34866982-A84158A2-4187-4658-8D0A-B8AAC5D36791Q34977034-21568736-7D3E-490D-894B-04B8DC4D54B9Q35006482-8618917C-93EC-4027-B9B6-3EF15160D410Q35110344-55138A01-0DAD-4A78-A745-9F5D039B98A8Q35168968-0911B645-F14E-424B-8445-A52483779371Q35273449-4316AE8D-9DE7-4AD9-975D-80343E3AD6ACQ35587213-4434C7AB-8FAF-475C-BE81-C8BE240AF4C5Q35665700-BFDF6FE6-F963-40EC-AF4E-BE8B6959A558Q35805563-110AEBF4-36C5-4B52-AFEF-7FE3A54B27CCQ35925834-C9E37BB4-6AAD-4149-9B0C-599D8483A274Q36017081-EB066610-AA3A-4EF6-85DC-2D5828585C88Q36326276-BB1C8669-C376-4721-BEDD-A399DCE1FE7FQ36380900-75C9F1AF-8AE1-481F-8D56-5E62F4F583C1Q36579186-28C96370-A239-497A-808D-58734808AAEBQ36590455-7CDF06DF-EAAC-4182-A7A4-39AF7BBE0CDBQ36648701-D99770D6-6A36-4F1D-8531-5D39677951AFQ36700634-A08A6B24-11CC-466B-BE0A-D71A5790CF8EQ36846038-8A8B9318-2406-4F9B-A8DE-4109C2EFD49BQ37085853-6F47F71D-E31F-49AB-8334-E0181369E5CDQ37349093-F59B8FC2-007B-49EB-9199-57082057AEDFQ37349459-8D00751B-0439-475A-8456-28FCE186954EQ37385204-1F6A126B-ECF3-4802-B0B3-73245F422509Q37640235-CFF2A622-1EAC-4F18-A8CC-ED99A31E724AQ37976277-3687133E-128C-4DCF-84AF-D3B0E49BCFBEQ38065487-96D8889B-0AF6-4C1C-9FFC-4DEE0DF370C3Q38078937-E0C1225F-FCE5-4719-A287-AE9FF984317F
P2860
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
@ast
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
@en
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
@nl
type
label
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
@ast
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
@en
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
@nl
prefLabel
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
@ast
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
@en
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
@nl
P1476
Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.
@en
P2093
P304
P356
10.1016/S0304-419X(01)00019-1
P407
P577
2001-03-01T00:00:00Z